A protein whose function is normally to define the prostate's development tells cells to continue growing in cancer. Study: NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting ...

Higher serum creatinine levels that are still within normal ranges are associated with a significantly increased risk of prostate cancer, according to a new study. Compared with patients in the lowest ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

In a recent study published in the journal Nutrients, researchers investigated the associations between urinary bisphenol A (BPA) concentrations (exposure) and the prostate-specific antigen (PSA; ...

Hormonal therapies are effective for recurrent and advanced prostate cancer, with PSA levels crucial for risk stratification. Combination hormone therapy is advised for metastatic prostate cancer, ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...